Brief: Willow BiosciencesAdvancing Program To Develop Precise, Concise Manufacturing Routes To Advanced Intermediates, High-Value Active Pharma Ingredients
07/12/2023 12:07
Dec 7 (Reuters) - Willow Biosciences Inc WLLW.TO :
* WILLOW BIOSCIENCES:ADVANCING PROGRAM TO DEVELOP PRECISE,
CONCISE
MANUFACTURING ROUTES TO ADVANCED INTERMEDIATES, HIGH-VALUE
ACTIVE PHARMA INGREDIENTS
Source text for Eikon: ID:nPn5FqntZa
Further company coverage: WLLW.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Atlas Energy
See all newsBrief: Atlas Energy Corp. Announces Appointments To Subsidiary Board And Extension Of Tsxv Sandbox Exit Deadline
Brief: Atlas Energy Reports Second Quarter 2025 Financial Results
Brief: Atlas Energy Reports Second Quarter 2025 Financial Results
Brief: Atlas Energy Strengthens Leadership Team With Appointment Of Andy Duncan As Senior Executive
Brief: Willow Biosciences Announces Completion Of Transformative Recapitalization Transactions To Form Atlas Energy Corp